Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | LYB | LIN |
|---|---|---|
| Price | $57.28 | $465.54 |
| Change today | ▼ 0.33% | ▼ 1.92% |
| Market cap | $18.50B | $214.60B |
| Return, 3 months | +10.1% | -12.5% |
| Return, year to date | +36.7% | +10.3% |
| Return, 1 year | +25.7% | +1.1% |
| P/E (TTM) | -51.1 | 30.0 |
| P/B | 1.7 | 5.5 |
| P/E percentile vs own 5y | – | 5th |
| Dividend yield | 7.19% | 1.33% |
| Revenue growth (YoY, latest qtr) | – | +9.3% |
| Net profit growth (YoY) | – | +9.2% |
| Gross margin | – | 48.3% |
| Operating margin | – | 27.1% |
| Net margin | – | 20.4% |
| Return on equity | – | 18.7% |
| Analyst target vs. price | +22.4% | +20.4% |
| Analyst buy share | 55% | 85% |
| RSI (14) | 34 | 52 |
| 30-day volatility | 31.8% | 13.1% |
| Max drawdown, 1 year | -35.5% | -18.6% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
